Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
810 Bestgate Road
Suite 400
Annapolis, MD 21401Phone+1 410-897-6200Fax+1 410-266-7636
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Johns Hopkins HospitalInstructor, Internal Medicine, 2006 - 2007
- University of MichiganResidency, Internal Medicine, 2003 - 2006
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
- University of Michigan-Ann ArborBS, Microbiology, Phi Beta Kappa, Phi Kappa Phi, 1995 - 1999
Certifications & Licensure
- MD State Medical License 2006 - 2026
- TX State Medical License 2007 - 2011
- MI State Medical License 2003 - 2006
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow of the Year MD Anderson Cancer Center, 2010
- Chief Fellow for Education MD Anderson Cancer Center, 2008-2009
- Best Teacher Award MD Anderson Cancer Center, 2008-2009
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Publications & Presentations
PubMed
- 63 citationsOphthalmic manifestations of leukemia.Katherine E. Talcott, Ravin J. Garg, Sunir J. Garg
Current Opinion in Ophthalmology. 2016-11-01 - 119 citationsThe use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-upRavin J. Garg, Hagop M. Kantarjian, Susan O'Brien, Alfonso Quintás-Cardama, Stefan Faderl
Blood. 2009-11-12 - 42 citationsPhase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeRavin J. Garg, Stefan Faderl, Guillermo Garcia-Manero, Jorge E. Cortes, Charles Koller
Leukemia. 2009-02-26
Press Mentions
- In Proportion: Approaches for Displaying Patient-Reported Outcome Research Study Results as Percentages Responding to TreatmentNovember 29th, 2018
- Presenting Comparative Study PRO Results to Clinicians and Researchers: Beyond the Eye of the BeholderNovember 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: